Literature DB >> 11420761

Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes.

M R Shah1, V Hasselblad, S S Stinnett, M Gheorghiade, K Swedberg, R M Califf, C M O'Connor.   

Abstract

BACKGROUND: Classifying patients with advanced congestive heart failure (CHF) by baseline measures of congestion and perfusion has been used to estimate hemodynamic status and to select and titrate therapy. We describe clinical characteristics of 4 hemodynamic profiles-wet/cold, wet/warm, dry/cold, and dry/warm-in patients with advanced CHF and assess relations between symptoms, physical signs, and outcomes with each profile. METHODS AND
RESULTS: We retrospectively assessed baseline symptoms, physical-examination variables, and 1-year outcomes of 440 patients in a randomized trial. With univariable and multivariable logistic regression, we examined relations of physical-examination variables to hemodynamic profiles. We also assessed the rates of death and death or readmission by profile. Severity of CHF symptoms did not predict the wet-versus-dry profile or cold-versus-warm status, despite significant differences in hemodynamics among groups. Of the physical-examination variables, only a lower proportional pulse pressure was a significant multivariable predictor of the wet category. Among wet patients (n = 348), this same variable was the only significant multivariable predictor of the cold category. For dry patients (n = 92), the cold category was predicted in multivariable analysis by supine heart rate and hepatomegaly. Survival was similar among profiles: wet/cold, 54.2% (n = 91); wet/warm, 58.3% (n = 105); dry/cold, 78.9% (n = 15); and dry/warm, 67.1%, P =.13 (n = 49). Event-free survival also was similar among profiles: wet/cold, 22.0% (n = 37); wet/warm, 29.4% (n = 53); dry/cold, 42.1% (n = 8); and dry/warm, 31.5%, P =.44 (n = 23).
CONCLUSIONS: The patient's history and physical examination alone may lead to inaccurate estimation of hemodynamic status and thus suboptimal management for patients with advanced CHF.

Entities:  

Mesh:

Year:  2001        PMID: 11420761     DOI: 10.1054/jcaf.2001.24131

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  15 in total

1.  Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.

Authors:  Mark H Drazner; Anne S Hellkamp; Carl V Leier; Monica R Shah; Leslie W Miller; Stuart D Russell; James B Young; Robert M Califf; Anju Nohria
Journal:  Circ Heart Fail       Date:  2008-09       Impact factor: 8.790

2.  Low pulse pressure as a predictor of death in patients with mild to advanced heart failure.

Authors:  Tansel Yildiran; Mevlut Koc; Abdi Bozkurt; Durmus Yildiray Sahin; Ilker Unal; Esmeray Acarturk
Journal:  Tex Heart Inst J       Date:  2010

3.  Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration.

Authors:  T Sadowski; S Dietrich; F Koschinsky; A Ludwig; E Proksch; B Titz; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2005-04       Impact factor: 9.261

4.  Longer-than-average length of stay in acute heart failure : Determinants and outcomes.

Authors:  H R Omar; M Guglin
Journal:  Herz       Date:  2017-02-06       Impact factor: 1.443

5.  Rise in BNP despite appropriate acute decompensated heart failure treatment : Patient characteristics and outcomes.

Authors:  H R Omar; M Guglin
Journal:  Herz       Date:  2016-09-13       Impact factor: 1.443

Review 6.  Invasive monitoring in patients with heart failure.

Authors:  Saima Husain; Salpy V Pamboukian; Josè A Tallaj; David C McGiffin; Robert C Bourge
Journal:  Curr Cardiol Rep       Date:  2009-05       Impact factor: 2.931

7.  Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.

Authors:  Michael S Kiernan; E Wilson Grandin; Marshall Brinkley; Navin K Kapur; Duc Thinh Pham; Robin Ruthazer; J Eduardo Rame; Pavan Atluri; Edo Y Birati; Guilherme H Oliveira; Francis D Pagani; James K Kirklin; David Naftel; Robert L Kormos; Jeffrey J Teuteberg; David DeNofrio
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

8.  Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).

Authors:  Amer H S Aljundi; Shaban F K Mohammed; Ashfaq Patel; Rajvir Singh; Abdulrahman Arabi; Hajar A AlBinali; Jassim Al Suwaidi
Journal:  BMC Cardiovasc Disord       Date:  2016-02-19       Impact factor: 2.298

9.  Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Corstiaan A den Uil; Wim K Lagrand; Martin van der Ent; Koen Nieman; Ard Struijs; Lucia S D Jewbali; Alina A Constantinescu; Peter E Spronk; Maarten L Simoons
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles.

Authors:  Tariq Ahmad; Nihar Desai; Francis Wilson; Phillip Schulte; Allison Dunning; Daniel Jacoby; Larry Allen; Mona Fiuzat; Joseph Rogers; G Michael Felker; Christopher O'Connor; Chetan B Patel
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.